Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • peptide

    - PMLiVE

    Eli Lilly to expand long-standing Purdue University partnership with $250m investment

    The alliance will aim to bring medicines to patients faster using advanced technologies

    - PMLiVE

    AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

    The funds will go towards a new global research and development centre in Beijing’s BioPark

    - PMLiVE

    Chiesi Group invests €400m to establish biotech centre of excellence in Italy

    The facility is dedicated to developing and producing monoclonal antibodies, enzymes and other proteins

    - PMLiVE

    Eli Lilly announces new $4.5bn US site for manufacturing and drug development

    The Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers

    - PMLiVE

    Answering some of Pharma’s big questions to drive brand strategies

    By James Aird and Zoë van Helmond

    Amiculum

    - PMLiVE

    FDA establishes rare disease innovation hub to accelerate treatment development

    More than 30 million people in the US are currently affected by a rare disease

    - PMLiVE

    Experts issue call for new ‘toolbox’ to simplify early-phase clinical trial regulation in UK

    The article outlines several recommendations to help improve early-phase clinical trials

    - PMLiVE

    Sanofi, Formation Bio and OpenAI announce AI collaboration to accelerate drug development

    The companies will combine data, software and tuned models to bring new medicines to patients more efficiently

    - PMLiVE

    AI drug discovery biotech Xaira Therapeutics launches with over $1bn in committed funding

    The company combines machine learning, data generation and therapeutic product development

    - PMLiVE

    Early strategic planning: how to get ahead of the curve

    By James Aird and Sarah Theobald

    Amiculum

    - PMLiVE

    Date set for EU antitrust regulators to decide on Pfizer’s $43bn Seagen acquisition

    The proposed transaction would mark a significant boost to the US pharma’s oncology pipeline

    - PMLiVE

    FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

    Origins announces the first speaker on the panel of our upcoming webinar

    Origins – The Patient Focused Specialists

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links